Intelgenx Technologies (Intelgenx Technologies) Growth Rank : 1 (As of Apr. 27, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Intelgenx Technologies Growth Rank?

Intelgenx Technologies has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Intelgenx Technologies's Growth Rank

For the Biotechnology subindustry, Intelgenx Technologies's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelgenx Technologies's Growth Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Growth Rank distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's Growth Rank falls into.

Intelgenx Technologies Growth Rank Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelgenx Technologies (Intelgenx Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (OTCPK:IGXT) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

0IL:Germany IGX:Canada

Address

6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2

Website

https://www.intelgenx.com

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Executives

Atai Life Sciences Ag	10 percent owner	KRAUSENSTRASSE 9-10, BERLIN 2M 10117
Atai Life Sciences N.v.	10 percent owner	524 BROADWAY, NEW YORK NY 10013
Karen Kalayajian	officer: VP, Finance&Admin - Subsidiary	4896 RUE EDOUARD-BRUNETTE, LAVAL A8 H7T 0J4
Dwight Gorham	officer: CEO	15B BARKLEY ST, ARNPRIOR A6 K7S 3G8
David Kideckel	officer: SVP, Corp. Dev&SA - Subsidiary	23 PEVERIL HILL SOUTH, TORONTO, ON A6 M6C 3A7
Horst G Zerbe	10 percent owner, officer: Chief Executive Officer	714 MAIN ROAD, HUDSON A8 JOP1H0
Andre Godin	officer: CFO	440 DES CARMANTINES, LAVAL A8 H7X 0B6
Tommy Kenny	officer: VP IP,Lgl Affairs - Subsidiary	88 CH. DES SAULES, ST-ADOLPHE D' HOWARD A8 J0T 2B0
Dana Matzen	officer: VP Business+Corp. Development	4771 RUE SHERBROOKE O., WESTMOUNT A8 H3Z1G5
Ingrid Zerbe	10 percent owner, officer: Corporate Secretary	714 MAIN ROAD, HUDSON A8 J0P1H0
Rodolphe Obeid	officer: Vice President, Operations	4779 RUE VILLERET, PIERREFOND A8 H9K1P6
Bernard Boudreau	director	2 TURNMILL DR., HALIFAX A5 B3M4H2
John Edward Durham	officer: Vice President Manufacturing	102 MAYFAIR, HUDSON A8 J0P1H0
Mark Nawacki	director	118 ARLINGTON AVENUE, WESTMOUNT A8 H3Y2W4
Robert J. Bechard	officer: VP Corporate Development	141 EASTON AVENUE, MONTREAL WEST A8 H4X 1L4